32 results
8-K
EX-2.2
acxga
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
8-K
EX-2.1
9wf2l 31z5r3w5hj3vv3
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
8-K
EX-2.3
3z7w 0jn0
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
8-K
EX-10.2
bi2vosl
29 Sep 14
NeoStem Secures Debt Facility
12:00am
8-K
EX-2.1
nwirgx 1jw
14 Apr 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.4
qc8g4 lhuj
13 Dec 13
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
mn0fp hwirctv
17 Oct 11
NeoStem Acquires Amorcyte, a Clinical Stage Cardiovascular Disease Cell Therapy Company
12:00am
8-K
EX-2.1
k1kkx3iq8ij8cd4
14 Jul 11
Entry into a Material Definitive Agreement
12:00am
425
EX-2.1
81ehu3ehjm7qt
14 Jul 11
Business combination disclosure
12:00am